- US regulators are struggling to complete inspections of drug factories that have been halted due to Covid-19, AP findsABC News
- FDA has a huge backlog of factory inspections as workers move to private sector jobsThe Associated Press
- USFDA struggling to conduct pending drug inspections even after CovidBusiness Standard
- Are you prepared for the coming wave of regulatory compliance?Clinical Leader
- Reconnaissance: AP report claims FDA has more than 2,000 pending inspections; Lycos CEO steps down after setback in MDMA drug caseRegulatory Focus